Risk Score for HCC in patients without Viral Hepatitis or Cirrhosis
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, shared an article by Ysabel C. Ilagan-Ying on X:
“Risk Score for HCC in pts Without Viral Hepatitis or Cirrhosis in JAMA Network Open.
Can we identify pts WITHOUT viral hep & cirrhosis at risk.
You need: age, sex, race/ ethnicity, BMI, DM, , & Fib-4.
Important, since MASLD & ALD are on the rise.”
Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.
Authors: Ysabel C. Ilagan-Ying, et al.
Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023